Substantive final action

HB3834

Senate: THIRD READING

Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.

Passed Senate April 29, 2026⭐ Substantive final action

33Yea

9Nay

0Not voting

6Absent

Group legislators by

Yea (33)

Jerry Alvord R

Micheal Bergstrom R

Mary Boren D

Michael Brooks D

David Bullard R

Bill Coleman R

Jo Dossett D

Avery Frix R

Christi Gillespie R

Todd Gollihare R

Regina Goodwin D

Grant Green R

Brian Guthrie R

Chuck Hall R

John Haste R

Carri Hicks D

Kelly Hines R

Brent Howard R

Darcy Jech R

Spencer Kern R

Julia Kirt D

Bryan Logan R

Mark Mann D

Nikki Nice D

Lonnie Paxton R

Roland Pederson R

Dave Rader R

Aaron Reinhardt R

Paul Rosino R

Brenda Stanley R

Jack Stewart R

Jonathan Wingard R

Tom Woods R

Nay (9)

George Burns R

Dusty Deevers R

Randy Grellner R

Warren Hamilton R

Shane Jett R

Julie McIntosh R

Dana Prieto R

Kendal Sacchieri R

Lisa Standridge R

Absent (6)

Julie Daniels R

Casey Murdock R

Adam Pugh R

Ally Seifried R

Kristen Thompson R

Darrell Weaver R

Open official vote record Open LegiScan roll call

Source provenance

LegiScan roll-call ID: 1691781
LegiScan bill ID: 2082076
Session ID: 2219
Individual records rendered: 48
Source file: var/states/oklahoma/source/legiscan/2219-befa0395515d/vote/1691781.json
Package observed: 2026-07-18T22:26:27+00:00
Final-action classification: Matched this state's reviewed final-vote patterns.

HB3834

Senate: THIRD READING

Yea (33)

Nay (9)

Absent (6)

Republicans (40)

Democrats (8)